Under this new rule, reproductive tissue , hematopoietic stem cells from umbilical cord blood and peripheral blood sources derived cellular therapies and other innovative products. ‘this new arrangements have been developed with input from many concerned consumers, associations and tissue banks in all cases we have examined carefully the comments in in the proposed rule and made changes in the final rule, if the science supports the change, Crawford said.. The new rule on donor eligibility concerns donors of traditional tissues such as muscle, skin and eye contact screened screened been necessary and tested for HIV, hepatitis B virus and hepatitis C virus since 1993.
Breast and prostate cancer genetic linkA new study shows that the risk of prostate cancer in men significantly, the proportion of families with an inherited form of breast and ovarian cancer are increased. Researchers at Memorial Sloan – Kettering Cancer Center have found that men wear in the family BRCA genetic mutations have a three to five – fold increased risk for prostate cancer. ‘While the association between hereditary breast and prostate cancer has been suggested that this is the first study of its kind, to confirm the connection ‘, Kenneth Offit, director of the Clinical Genetics Service said at Memorial Sloan – Kettering and senior author of the study, from the first in the May issue Clinical Cancer Research is published.A team UCLA associate professor of bioengineering Jacob Schmidt carried a cell-free artificial membrane technology for ion channel measurements, which saving time and savings in time and cost designed.
This technology is been exclusively by Librede which, in July 2008 Schmidt and Jason Poulos cell free CTO and co – that licensed established. Under this agreement, the University of California at of a license fee in the company’s future products .